POZEN Logo
Print Page   Close Window

Press Release

POZEN Announces October 30 Webcast of Third-Quarter Results

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Oct. 24, 2003--POZEN Inc. (NASDAQ:POZN), a pharmaceutical company developing therapeutic advancements in a cost effective manner, today announced it will host a conference call following the release of financial results for the third quarter ended September 30, 2003. The company will release results before the market opens on Thursday, October 30, 2003. John R. Plachetka, Pharm.D., POZEN's chairman, president and chief executive officer, and Matthew E. Czajkowski, chief financial officer, will host the conference call the same day at 11:00 a.m. Eastern Time.

The conference call will be simulcast live on the Internet, and can be accessed by logging on to www.pozen.com. A replay will be available for seven days in the Investor Relations section of the company's website. POZEN's third quarter results release can be accessed in the News section of www.pozen.com and by clicking on the release dated October 30, 2003.

POZEN is a pharmaceutical company developing therapeutic advancements in a cost effective manner. Product development efforts are focused on diseases with unmet medical needs where POZEN can improve efficacy, safety, and/or patient convenience. Since its inception, POZEN has developed the largest and most advanced product pipeline in the field of migraine. POZEN has development and commercial alliances with GlaxoSmithKline, Xcel Pharmaceuticals, and Nycomed. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN". For detailed company information, including copies of this and other press releases, see POZEN's website: www.pozen.com.

CONTACT:
POZEN Inc.
Matt Czajkowski
Chief Financial Officer
919-913-1030
or
Lisa Barthelemy
Director, Investor Relations
919-913-1044